Rational design and synthesis of a novel, selective class of thrombin inhibitors: P1-argininal derivatives incorporating P3P4 quaternary lactam dipeptide surrogates
摘要:
SAR and molecular modeling investigations on the potent and selective thrombin inhibitor 1b (CVS 1578) and related serine protease inhibitors led to the design of series 2a-g, featuring quaternary alpha-amino-alpha-benzyl-lactam scaffolds that serve as novel P-3-P-4 dipeptide mimics. The design, synthesis, and biological activity of these targets are presented. (C) 1997 Elsevier Science Ltd.
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I):
including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein Q
1
and Q
2
are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
[EN] OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION<br/>[FR] CONJUGUÉS LIGANDS D'OLIGONUCLÉOTIDES ET PROCÉDÉ POUR LEUR PRÉPARATION
申请人:ALNYLAM PHARMACEUTICALS INC
公开号:WO2015006740A3
公开(公告)日:2015-05-07
Rational design and synthesis of a novel, selective class of thrombin inhibitors: P1-argininal derivatives incorporating P3P4 quaternary lactam dipeptide surrogates
作者:J.Edward Semple、Nathaniel K. Minami、Susan Y. Tamura、Terence K. Brunck、Ruth F. Nutt、William C. Ripka
DOI:10.1016/s0960-894x(97)00446-0
日期:1997.9
SAR and molecular modeling investigations on the potent and selective thrombin inhibitor 1b (CVS 1578) and related serine protease inhibitors led to the design of series 2a-g, featuring quaternary alpha-amino-alpha-benzyl-lactam scaffolds that serve as novel P-3-P-4 dipeptide mimics. The design, synthesis, and biological activity of these targets are presented. (C) 1997 Elsevier Science Ltd.